Insulin lispro update

The Diabetes Educator
Jerry D Meece, R Keith Campbell

Abstract

This paper provides a review of the literature and clinical studies for insulin lispro and updated information on its advantages over regular insulin for various populations of people with diabetes. Information was gathered from a search of Medline articles and from review of clinical studies. Patients in various special populations using insulin lispro, with proper adjustment of basal insulin, had a greater reduction in hemoglobin A1C and fewer episodes of hypoglycemia than patients on regular insulin. More recently published literature shows that due to its faster onset and shorter duration of action, insulin lispro is useful for not only lowering A1C values, but also for reducing hypoglycemic events in various populations with diabetes, including pediatric and pregnant patients, those with gastroparesis, and insulin pump users.

References

Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
Mar 31, 1999·Diabetes Care·V A KoivistoP Ebeling
Sep 10, 1999·Diabetes Care·L JovanovicE J Bastyr

❮ Previous
Next ❯

Citations

Aug 20, 2004·QJM : Monthly Journal of the Association of Physicians·S A SaundersI A MacFarlane
Feb 25, 2005·Anesthesia and Analgesia·Zulfiqar AhmedGeorgiana Klingensmith

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.